AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $439,000 | -50.3% | 152,300 | -34.6% | 0.03% | -62.4% |
Q2 2021 | $883,000 | +94.9% | 233,003 | +74.0% | 0.08% | +102.4% |
Q1 2021 | $453,000 | +4.1% | 133,902 | -13.9% | 0.04% | -43.2% |
Q4 2020 | $435,000 | -13.5% | 155,583 | -22.4% | 0.07% | -26.7% |
Q3 2020 | $503,000 | – | 200,500 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
Anson Funds Management LP | 95,342 | $267,000 | 0.05% |